Phaseline

Targets › UBIQUINONE

UBIQUINONE: drug programs, companies and trials

1 program from 1 company in 1 trial: 1 Phase 3; Psychiatry; next expected readout Dec 2030.

Open in Phaseline: the race on UBIQUINONE, likelihood bands and readouts

Programs

CompanyDrugTargetsHighest phaseConditionsNext expected readout
Sherief Abd-ElsalamCoenzyme Q
Mitochondrial electron transport chain cofactor and antioxidant
UBIQUINONEPhase 3ADHDDec 2030

Conditions

ADHD (1)

Modalities

small molecule (1)

Companies

Sherief Abd-Elsalam (1)

Related targets

–

Programs group each company's trials by drug; targets and mechanisms come from Open Targets and ChEMBL via Open Targets; expected readouts are Phaseline's estimate from the registry's primary completion date. Facts from the registries only; the approval likelihood is in the app.